NEO-SV-01

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNEO-SV-01
Drug Alias NameNEO-SV-01
ClassificationVaccines
Mechanisms of ActionT lymphocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBioNTech US Inc
China Registration ClassN/A

Develop Information

Active CompaniesBioNTech US Inc
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A